HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine.

Abstract
A 31-year-old man with malignant melanoma of his right popliteal fossa was treated in 1987 with surgical excision followed by local radiotherapy. Eight months later, he presented with recurrence in the right inguinal lymph nodes, which were resected and followed by radiotherapy to the groin. Ten months later, he developed liver metastases and was treated with vindesine (12 months) and interferon-alpha-2a (30 months) resulting in complete remission which has been maintained for over 10 years. This interesting case report, with brief review of literature, is presented here.
AuthorsM Iqbal, E Marshall, J A Green
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 11 Issue 4 Pg. 483-5 (Apr 2000) ISSN: 0923-7534 [Print] England
PMID10847471 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interferon-alpha
  • Vindesine
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Disease-Free Survival
  • Humans
  • Interferon-alpha (therapeutic use)
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Melanoma (drug therapy, secondary)
  • Skin Neoplasms (pathology)
  • Vindesine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: